iBio, Inc.
IBIO
$2.22
$0.115.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.97% | 34.14% | 45.73% | 30.36% | 29.25% |
| Total Depreciation and Amortization | -30.08% | -28.80% | -31.84% | -34.07% | -3.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | -35.22% | -87.23% | -86.46% | 45.67% | -9.20% |
| Change in Net Operating Assets | 109.03% | 73.27% | 79.83% | -211.29% | -314.90% |
| Cash from Operations | 3.55% | 16.42% | 34.25% | 33.38% | 14.80% |
| Capital Expenditure | -160.19% | 83.81% | 99.05% | 58.30% | 30.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -88.00% | -97.51% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,494.98% | -1,350.20% | -24.20% | -28.80% | -71.18% |
| Cash from Investing | -1,659.09% | -1,467.11% | -16.56% | -45.69% | -81.09% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | 44.43% | 69.08% | 74.47% | 6.80% | 56.02% |
| Issuance of Common Stock | -65.70% | -87.88% | -90.54% | -4.67% | 27.49% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 66,282.95% | 59,751.14% | 6,863.64% | -- | -- |
| Cash from Financing | 259.66% | 150.38% | -67.89% | -10.98% | 65.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 646.32% | 194.37% | -152.25% | 124.08% | 2,763.06% |